The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
Open accessAbstract
Many people with type 2 diabetes mellitus (T2DM) fail to achieve glycaemic control promptly after diagnosis and do not receive timely treatment intensification. This may be in part due to 'clinical inertia', defined as the failure of healthcare providers to initiate or intensify therapy when indicated. Physician-, patient- and healthcare-system-related factors all contribute to clinical inertia. However, decisions that appear to be clinical inertia may, in fact, be only 'apparent' clinical inertia and may reflect good clinical practice on behalf of the physician for a specific patient. Delay in treatment intensification can happen at all stages of treatment for people with T2DM, including prescription of lifestyle changes after diagnosis, introduction of pharmacological therapy, use of combination therapy where needed and initiation of insulin. Clinical inertia may contribute to people with T2DM living with suboptimal glycaemic control for many years, with dramatic consequences for the patient in terms of quality of life, morbidity and mortality, and for public health because of the huge costs associated with uncontrolled T2DM. Because multiple factors can lead to clinical inertia, potential solutions most likely require a combination of approaches involving fundamental changes in medical care. These could include the adoption of a person-centred model of care to account for the complex considerations influencing treatment decisions by patients and physicians. Better patient education about the progressive nature of T2DM and the risks inherent in long-term poor glycaemic control may also reinforce the need for regular treatment reviews, with intensification when required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Defining and Characterizing the Progression of Type 2 Diabetes
Fonseca, V. A. (2009) · Diabetes Care · doi:10.2337/dc09-s301 · Cited by 573
Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care
Safford, M. M., Shewchuk, R., Qu, H., Williams, J. H., Estrada, C. A., Ovalle, F., & Allison, J. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0433-8 · Cited by 132
Greenwood, D. A., Blozis, S. A., Young, H. M., Nesbitt, T. S., & Quinn, C. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4112 · Cited by 128
Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care
Mata-Cases, M., Benito-Badorrey, B., Roura-Olmeda, P., Franch-Nadal, J., Pepió-Vilaubí, J. M., Saez, M., Coll-de-Tuero, G., & on behalf of the GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833089 · Cited by 70
Frequency of inappropriate medical exceptions to quality measures
Persell, S. D., Dolan, N. C., Friesema, E. M., Thompson, J. A., Kaiser, D., & Baker, D. W. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-4-201002160-00007 · Cited by 66
Cited by
Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc18-0287 · Cited by 391
Gandhi, G. R., Vasconcelos, A. B. S., Wu, D.-T., Li, H.-B., Antony, P. J., Li, H., Geng, F., Gurgel, R. Q., Narain, N., & Gan, R.-Y. (2020) · Nutrients · doi:10.3390/nu12102907 · Cited by 279
Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review
Okemah, J., Peng, J., & Quiñones, M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0819-5 · Cited by 211
Khunti, S., Khunti, K., & Seidu, S. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819844694 · Cited by 182
Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., & Mannino, D. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00559-7 · Cited by 128
Metadata
- Authors
- Reach, G., Pechtner, V., Gentilella, R., Corcos, A., & Ceriello, A.
- Venue
- Diabetes & Metabolism
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 43
- Issue
- 6
- Pages
- 501-511
- ISSN
- 1262-3636 (ISSN-L)
- OpenAlex
- W2738595939
- Cited by
- 251
- References
- 18
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1016/j.diabet.2017.06.003
- The paper
- Reach, G., Pechtner, V., Gentilella, R., Corcos, A., & Ceriello, A. (2017). Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes & Metabolism. https://doi.org/10.1016/j.diabet.2017.06.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.